HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

chlorambucil-taurocholate

Also Known As:

3H-chlorambucil-taurocholate; S 2676; S2676

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 10/01/1997 - "Expression of hepatocellular carcinoma mRNA in oocytes resulted in mainly Na(+)-dependent uptake of chlorambucil-taurocholate. " 10/01/1997 - "Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas." 10/01/1997 - "Because NTCP mediates high-affinity uptake of chlorambucil-taurocholate, targeting of cytostatic bile acids to hepatocellular carcinomas could become a feasible therapeutic strategy."
2.	Carcinoma (Carcinomatosis) 10/01/1997 - "Uptake of the cytostatic drug [3H]-chlorambucil-taurocholate (S2676) was measured in Xenopus laevis oocytes injected with total messenger RNA (mRNA) from the carcinomas or peritumor tissue or with complementary RNA encoding the NTCP or the organic anion-transporting polypeptide (OATP) of human liver. "

Related Drugs and Biologics

1.	chlorambucil-taurocholate
2.	Cytostatic Agents
3.	Complementary RNA (cRNA)
4.	Messenger RNA (mRNA)
5.	Peptides (Polypeptides)
6.	Bile Acids and Salts (Bile Acids)
7.	Anions